Analyst Ratings for VistaGen Therapeutics (VTGN)
VTGN Rating Summary
VTGN Price Target Summary
- Highest: $1.00 (Stifel)
- Lowest: $0.90 (Jefferies)
- Average: $0.97
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$0.97 (+72.6%)
* Over Last 12-Mos
Rating Score: 2.2 / 10
Percentile Rank: 17%
Rating Score: 2.2 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/17/2025 | Jefferies | Andrew Tsai | Downgrade | Hold (Buy) |
0.90 (15.00) |
4.36 (0.56) |
-87.16% | Details |
| 12/17/2025 | Maxim Group | Jason McCarthy | Downgrade | Hold (Buy) |
N/A (N/A) |
4.36 (0.56) |
-87.16% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


